283 related articles for article (PubMed ID: 29326012)
1. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
3. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
4. Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.
Comito T; Cozzi L; Zerbi A; Franzese C; Clerici E; Tozzi A; Iftode C; Navarria P; D'Agostino G; Fogliata A; Mancosu P; Tomatis S; Carnaghi C; Personeni N; Santoro A; Scorsetti M
Eur J Surg Oncol; 2017 Apr; 43(4):735-742. PubMed ID: 28131670
[TBL] [Abstract][Full Text] [Related]
5. Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
Comito T; Cozzi L; Clerici E; Franzese C; Tozzi A; Iftode C; Navarria P; D'Agostino G; Rimassa L; Carnaghi C; Personeni N; Tronconi MC; De Rose F; Franceschini D; Ascolese AM; Fogliata A; Tomatis S; Santoro A; Zerbi A; Scorsetti M
Technol Cancer Res Treat; 2017 Jun; 16(3):295-301. PubMed ID: 27311310
[TBL] [Abstract][Full Text] [Related]
6. SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.
Tozzi A; Comito T; Alongi F; Navarria P; Iftode C; Mancosu P; Reggiori G; Clerici E; Rimassa L; Zerbi A; Fogliata A; Cozzi L; Tomatis S; Scorsetti M
Radiat Oncol; 2013 Jun; 8():148. PubMed ID: 23799996
[TBL] [Abstract][Full Text] [Related]
7. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
Pollom EL; Alagappan M; von Eyben R; Kunz PL; Fisher GA; Ford JA; Poultsides GA; Visser BC; Norton JA; Kamaya A; Cox VL; Columbo LA; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):918-25. PubMed ID: 25585785
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma.
Lin C; Verma V; Ly QP; Lazenby A; Sasson A; Schwarz JK; Meza JL; Are C; Li S; Wang S; Hahn SM; Grem JL
Radiother Oncol; 2019 Mar; 132():55-62. PubMed ID: 30825970
[TBL] [Abstract][Full Text] [Related]
9. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
Herman JM; Chang DT; Goodman KA; Dholakia AS; Raman SP; Hacker-Prietz A; Iacobuzio-Donahue CA; Griffith ME; Pawlik TM; Pai JS; O'Reilly E; Fisher GA; Wild AT; Rosati LM; Zheng L; Wolfgang CL; Laheru DA; Columbo LA; Sugar EA; Koong AC
Cancer; 2015 Apr; 121(7):1128-37. PubMed ID: 25538019
[TBL] [Abstract][Full Text] [Related]
10. Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma.
Poiset SJ; Shah S; Cappelli L; Anné P; Mooney KE; Werner-Wasik M; Laufer TS; Posey JA; Lin D; Basu Mallick A; Lavu H; Bashir B; Yeo CJ; Mueller AC
Radiat Oncol; 2024 May; 19(1):65. PubMed ID: 38812040
[TBL] [Abstract][Full Text] [Related]
11. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
12. Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer.
Lin JC; Jen YM; Li MH; Chao HL; Tsai JT
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):259-64. PubMed ID: 25629569
[TBL] [Abstract][Full Text] [Related]
13. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.
Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K
J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263
[TBL] [Abstract][Full Text] [Related]
14. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer.
Sanders MK; Moser AJ; Khalid A; Fasanella KE; Zeh HJ; Burton S; McGrath K
Gastrointest Endosc; 2010 Jun; 71(7):1178-84. PubMed ID: 20362284
[TBL] [Abstract][Full Text] [Related]
15. Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer.
Cuccia F; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Corradini S; Ruggieri R; Alongi F
Strahlenther Onkol; 2020 Jul; 196(7):628-636. PubMed ID: 32399638
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.
Su TS; Liang P; Lu HZ; Liang JN; Liu JM; Zhou Y; Gao YC; Tang MY
World J Gastroenterol; 2015 Jul; 21(26):8156-62. PubMed ID: 26185389
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]